Intestinal fortitude: Gut coils hold secrets of organ formation

A new study reveals how vertebrate guts form, with implications for how other organs develop.

Discovery illuminates how Parkinson’s disease spreads in the brain

Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.

App for the pre-K set promotes healthy eating, exercise

A series of free, evidence-informed apps for preschool-aged children, developed by a Cornell researcher and colleagues, aims to encourage healthy eating behaviors and exercise.

Aggressive breast cancer linked to African ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.

Discovery explains cancer chemotherapy resistance, offers solution

Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.

Alzheimer’s disease causes major metabolic changes in the brain

New findings could lead to the development of treatments aimed at ameliorating the metabolic effects of the disease.

Male contraception offers promise in post-Roe v. Wade era

Paula Cohen, professor of genetics, is pioneering an innovative alternative to the birth control pill: a form of male contraception that targets a mechanism in the early stage of sperm cell production. 

Collaboration to infuse human behavior into epidemiological models

Six Cornell faculty members from three different colleges will work together to improve epidemiological models of infectious disease, including by better incorporating human behavior into the models, using a $1 million grant from the National Science Foundation.

Around Cornell

Proteins could lead to early breast cancer diagnosis, treatment

A team of researchers has discovered a non-invasive biomarker that could aid with earlier diagnosis of breast cancer, the most common cancer among women, which will likely affect one in 13 women during their lives.